Lloyd Dias

Title: The Innovations of Lloyd Dias

Introduction

Lloyd Dias is an accomplished inventor based in Gurnee, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid dispersions containing kinase inhibitors. His innovative work has the potential to impact cancer treatment positively.

Latest Patents

Lloyd Dias holds a patent for a solid dispersion that comprises, in essentially non-crystalline form, a kinase inhibitory compound. This compound, specifically N-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl}phenyl)-N'-(3-fluorophenyl)urea, is dispersed in a solid matrix that includes a pharmaceutically acceptable water-soluble polymeric carrier and a surfactant. The process for preparing this solid dispersion involves dissolving the compound, the polymeric carrier, and the surfactant in a suitable solvent, followed by the removal of the solvent to create a solid matrix. This innovation is particularly suitable for oral administration to patients in need of cancer treatment. Lloyd Dias has 1 patent to his name.

Career Highlights

Throughout his career, Lloyd Dias has worked with notable companies such as AbbVie Inc. and AbbVie Bahamas Limited. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical technology.

Collaborations

Lloyd has collaborated with talented individuals in his field, including Jonathan Miller and Rajeev Gokhale. These partnerships have fostered innovation and enhanced the development of new therapeutic solutions.

Conclusion

Lloyd Dias is a prominent inventor whose work in solid dispersions for kinase inhibitors showcases his dedication to improving cancer treatment. His contributions to the pharmaceutical industry are noteworthy and reflect his commitment to innovation.